Japfa (JAP)

Agri-food company Japfa saw its earnings surge 500% to US$76.8 million ($105.7 million) for 1H20 ended June, from $12.8 million a year ago, due to strong performance registered from both Animal Protein – Other (APO) in Vietnam, and Dairy.

DBS analysts Andy Sim and Alfie Yeo are maintaining their “buy” calls on Japfa on the company’s geographically diverse portfolio.

Japfa Holdings's earnings for 1Q20 ended March increased by 353.9% to US$35.5 million (S$50.3 million) compared to US$7.8 million a year ago.

SINGAPORE (Dec 12): Maybank Kim Eng is maintaining Japfa at “buy” with higher 99 cents target price, fuelled by the rebound in its PT Japfa Tbk (JPFA) and Animal Protein Other (APO) divisions.

SINGAPORE (Nov 1): UOB KayHian is maintaining Japfa at “buy” after 3Q18 core net profit beat its Street-high 2018 forecast significantly with 9M18 net profit meting 95% of its and 105% of consensus 2018 forecasts.

SINGAPORE (Oct 30): Japfa, the vertically-integrated agri-food company, reported 3Q earnings surged nearly fivefold to US$14.3 million ($19.8 million) from a year ago, lifted by stronger performance across most business segments.

SINGAPORE (Sept 6): Helped by an upturn in the poultry and swine industries in Indonesia and Vietnam respectively, livestock producer Japfa has done well in 2Q18 ended June 30.

SINGAPORE (June 9): DBS Vickers is rating Japfa (JAP) a “buy” with $1.10 target price after Japfa Comfeed Indonesia (JPFA) announced it had on Wednesday entered into subscription agreement with KKR Jade Investments (KKR).